MEOD Stock Overview
Ceconomy AG, together with its subsidiaries, engages in the consumer electronics retail business.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Ceconomy AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.39 |
| 52 Week High | €0.50 |
| 52 Week Low | €0.27 |
| Beta | 2.24 |
| 1 Month Change | 34.93% |
| 3 Month Change | -5.74% |
| 1 Year Change | -14.72% |
| 3 Year Change | -51.06% |
| 5 Year Change | -59.80% |
| Change since IPO | -93.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEOD | DE Specialty Retail | DE Market | |
|---|---|---|---|
| 7D | 4.2% | 0.9% | -1.5% |
| 1Y | -14.7% | -19.5% | 0.9% |
Return vs Industry: MEOD exceeded the German Specialty Retail industry which returned -18.4% over the past year.
Return vs Market: MEOD underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| MEOD volatility | |
|---|---|
| MEOD Average Weekly Movement | 14.8% |
| Specialty Retail Industry Average Movement | 7.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MEOD's share price has been volatile over the past 3 months.
Volatility Over Time: MEOD's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 41,365 | Karsten Wildberger | www.ceconomy.de |
Ceconomy AG, together with its subsidiaries, engages in the consumer electronics retail business. It operates stores under the MediaMarkt and Saturn brands. The company offers professional assistance for the installation, connection, and troubleshooting of electronic devices at home under the Deutsche Technikberatung brand.
Ceconomy AG Fundamentals Summary
| MEOD fundamental statistics | |
|---|---|
| Market cap | €1.08b |
| Earnings (TTM) | -€19.00m |
| Revenue (TTM) | €22.16b |
0.0x
P/S Ratio-57.1x
P/E RatioIs MEOD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEOD income statement (TTM) | |
|---|---|
| Revenue | €22.16b |
| Cost of Revenue | €18.22b |
| Gross Profit | €3.94b |
| Other Expenses | €3.96b |
| Earnings | -€19.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | -0.039 |
| Gross Margin | 17.77% |
| Net Profit Margin | -0.086% |
| Debt/Equity Ratio | 437.1% |
How did MEOD perform over the long term?
See historical performance and comparison